RVLPQ
RVL Pharmaceuticals plc

2,760
Loading...
Loading...
RVL Pharmaceuticals Plc engages in the development and commercialization of products for neurology and women's health. Its products include Upneeq, M-72, Arbaclofen ER, OS870, Divigel, OB Complete, Methylphenidate ER, Venlafaxine ER tablets (VERT), Hydromorphone ER, Sodium Benzoate/Sodium Phenylacetate, Oxybutynin ER, Prescription Prenatal Vitamins, Chlorzoxazone (Lorzone AG), Tramadol ER (ConZip AG), Nitrofurantoin and Osmodex ANDAs. The company was founded in 1986 and is headquartered in Bridgewater, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of RVL Pharmaceuticals plc?
What is the 52-week high for RVL Pharmaceuticals plc?
What is the 52-week low for RVL Pharmaceuticals plc?
What is the 50-day moving average of RVL Pharmaceuticals plc?

Latest RVLPQ News

View
No RVLPQ news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.